ss 31 peptide for sale online

Evaluating SS 31 Peptide for Sale Online: Sourcing and Vendor Selection Criteria

When sourcing an SS 31 peptide for sale online, laboratory investigators must establish strict vendor qualification parameters to prevent batch-to-batch variability and experimental distortion. Peptides designated for in vitro assays and animal models demand rigorous synthesis standards, validated chemical identity, and full analytical disclosure before integration into research workflows. Inconsistent purity or undetected residual counter-ions can confound bioenergetic assays, alter mitochondrial membrane potential readouts, and invalidate published findings.

PX1 Research maintains a fully transparent supply chain for academic and corporate research entities. When acquiring compounds from our catalog of research peptides, principal investigators receive comprehensive lot-specific documentation verifying structural identity, high chemical purity, and ultralow endotoxin levels. Facilities conducting high-throughput screening or multi-phase animal studies can also access our bulk research program to reserve single-lot batches, ensuring strict experimental continuity across long-term protocols.

Molecular Structure and Biochemical Profile of SS-31 (Elamipretide)

SS-31, chemically recognized as Elamipretide or Bendavia, is a synthetic tetrapeptide featuring the amino acid sequence D-Arg-Dmt-Lys-Phe-NH2 (where Dmt represents 2',6'-dimethyl-L-tyrosine). Unlike conventional hydrophobic or large macromolecular compounds that require active transport systems or liposomal delivery vehicles to traverse cell boundaries, the structural motif of SS-31 confers intrinsic cell-permeability across diverse cell lines.

The presence of alternating basic residues (arginine and lysine) alongside aromatic amino acids generates a balanced amphipathic, water-soluble conformation with a net positive charge at physiological pH. Preclinical structural analysis demonstrates that this specific aromatic-cationic sequence allows SS-31 to selectively concentrate at the inner mitochondrial membrane (IMM) by a factor of more than 1,000-fold compared to extra-mitochondrial cytoplasmic space, without disrupting normal resting cellular membrane potential.

Mechanism of Action: Cardiolipin Interaction and Inner Mitochondrial Membrane Support

The primary mechanism of action characterized in preclinical literature centers on the high-affinity binding of SS-31 to cardiolipin, a unique tetra-acylglycerol phospholipid localized almost exclusively within the inner mitochondrial membrane. Cardiolipin plays a critical structural role in organizing respiratory chain supercomplexes (respirasomes), stabilizing mitochondrial cristae architecture, and anchoring cytochrome c to facilitate efficient inter-protein electron transfer.

Under conditions of induced metabolic stress or elevated reactive oxygen species (ROS) in cell models, cardiolipin undergoes peroxidation, leading to structural destabilization of the IMM, disassembly of respiratory complexes, and inappropriate cytochrome c release. In vitro research demonstrates that SS-31 electrostatic and hydrophobic interactions insert into the cardiolipin headgroups, stabilizing membrane curvature and preventing ROS-mediated lipid peroxidation. By preserving cardiolipin integrity, SS-31 helps maintain optimal electron transport kinetics and prevents mitochondrial permeability transition pore (mPTP) opening.

Preclinical Research Focus: Bioenergetics, ATP Yield, and Oxidative Stress Mitigation

Investigative focus on the SS-31 10mg peptide spans a broad range of physiological and biochemical domains in preclinical models. Research teams utilize this targeted tetrapeptide to measure changes in cellular oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and total cellular ATP yield under chemically induced mitochondrial stress.

Key areas of active preclinical inquiry include:

• Mitochondrial Respiration Efficiency: Assessing the recovery of state 3 respiration and respiratory control ratios (RCR) in isolated mitochondria subjected to ischemic or oxidative damage.

• ROS Attenuation: Measuring the direct reduction of mitochondrial superoxide generation without suppressing physiological signaling ROS levels in cytosolic compartments.

• Ischemia-Reperfusion Models: Evaluating cellular survival and microvascular preservation in animal models of localized tissue hypoxia.

• Neuromuscular and Metabolic Readouts: Investigating age-related mitochondrial decay, muscle fatigue kinetics, and neuroprotective pathways in rodent disease models.

Data compiled across these diverse experimental setups consistently highlight SS-31 as a primary pharmacological tool for modulating organelle-level bioenergetics without directly targeting specific cell-surface receptors.

Comparative Analysis: SS-31 vs. MOTS-c vs. Humanin

To properly contextualize mitochondrial research vectors, laboratories frequently evaluate SS-31 alongside mitochondrial-derived peptides (MDPs) such as MOTS-c and Humanin. While all three compounds modulate bioenergetic and metabolic pathways, their precise targets, structural features, and downstream signaling mechanisms differ substantially.

SS-31 functions directly at the physical lipid interface of the IMM through non-covalent cardiolipin binding, offering rapid physical stabilization of respiratory supercomplexes. In contrast, the MOTS-c peptide research model demonstrates that MOTS-c acts primarily as a nuclear-translocating metabolic regulator, targeting the folate cycle and activating AMPK to control systemic insulin sensitivity and glucose homeostatic pathways (evaluated via MOTS-c 5mg product). Meanwhile, Humanin peptide operates predominantly via extracellular receptor signaling (such as FPRL1) and interaction with pro-apoptotic proteins (Bax, tBid) to suppress programmed cell death pathways. Researchers selecting compounds from our PX1 research library often deploy these peptides in combination or comparative protocols to delineate structural membrane protection from systemic transcription-factor signaling.

Analytical Purity Verification and Standardized Quality Control

PX1 Research enforces strict quality control standards for every batch of SS-31 synthesized. Because trace chemical impurities, peptide truncations, or residual trifluoroacetic acid (TFA) salts can distort delicate enzyme kinetic assays and cell culture viability metrics, our quality assurance protocols exceed basic commercial standards.

Every production lot undergoes reverse-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity at ≥98.0%. Electrospray ionization mass spectrometry (ESI-MS) confirms exact molecular mass identity (C32H49N9O5, monoisotopic mass ~639.38 g/mol). Furthermore, all batches are evaluated using Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin content remains strictly below 0.01 EU/mg. Certificate of Analysis (COA) documentation detailing exact analytical spectra is provided with every dispatch.

Laboratory Reconstitution, Handling, and Storage Guidelines

Lyophilized SS-31 is supplied as a stable, white to off-white powder. To maintain chemical stability and prevent premature degradation upon arrival at the laboratory facility, strict adherence to standardized storage protocols is required.

Upon receipt, unopened vials should be stored at -20°C or -80°C for long-term stability. Prior to reconstitution, vials must be allowed to equilibrate to room temperature inside a desiccator or sealed container to prevent atmospheric condensation from contaminating the cake. Reconstitution should be performed using sterile laboratory-grade water or phosphate-buffered saline (PBS, pH 7.4). For complete step-by-step instructions on liquid handling, master stock preparations, and freeze-thaw avoidance, refer to our comprehensive reconstitution protocol guidelines. Once reconstituted, working aliquots should be frozen immediately at -80°C to maintain structural integrity over repeated assay cycles.

US Manufacturing, Supply Chain Integrity, and Same-Day Dispatch

PX1 Research eliminates supply chain vulnerabilities for domestic and international research operations. All research compounds are synthesized in state-of-the-art, GMP-compliant facilities located within the United States, operating under ISO 17025 accredited laboratory oversight.

To prevent project delays, all orders placed before 12:00 PM PST Monday through Friday ship same-day directly from our centralized logistics centers in California and Arizona. Secure packaging includes temperature-controlled insulation when environmental parameters require it, ensuring that your facility receives stable, uncompromised reagents ready for immediate experimental deployment.